Integra LifeSciences Holdings (IART) Dividend History

Company News

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

  Integra LifeSciences Holdings Corporation reported weaker-than-expected financial results for the first quarter of 2025, leading to a significant drop in its stock price. The Pomerantz Law Firm is investigating potential securities fraud or other unlawful business practices by the company and its officers.

  GlobeNewswire Inc.
• Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology

  The chronic wound care market is expected to grow at a CAGR of 4.17% from 2024 to 2031, driven by the high prevalence of chronic diseases and advancements in wound care technologies. The market is segmented by product, application, end-user, and region, with North America leading due to its developed healthcare infrastructure.

  Benzinga

  Featured Companies: BAX CAH JNJ MDXG MMM
• Why Integra Lifesciences Stock Is Sinking Today

  Integra Lifesciences (IART) shares fell 15.5% after the company reported Q2 results that topped estimates but provided disappointing full-year guidance, citing operational challenges and investments in compliance improvements.

  The Motley Fool
• Why Is Integra (IART) Up 26% Since Last Earnings Report?

  Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  Zacks Investment Research

  Featured Companies: AVNS